Meet us at EuSEM 2018, the 12th European Congress on Emergency Medicine, on September 8-12 in Glasgow, Scotland and hear the suPAR presentations.

Visit us at the ViroGates booth no.18 where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks!

See the following suPAR presentations at EuSEM:

Free Paper 1: Biomarkers

Sunday, 13.00—14.30, Room Gala, Session F11

• Kevin Bronton (Malmö, Sweden):
“Biomarker risk-stratification of patients with acute dyspnea at the emergency department
using soluble urokinase-type Plasminogen Activating Receptor: A prospective suPAR study
from Sweden” (#FP005)
• Martin Schultz (Herlev, Denmark):
“Use of the prognostic biomarker soluble urokinase plasminogen activator receptor in the
emergency department does not affect mortality, a cluster-randomised clinical trial”
• Martin Schultz (Herlev, Denmark):
“Early discharge from the emergency department based on soluble urokinase plasminogen
activator receptor levels: a sub-study of the triage iii trial” (#FP008)

e-Poster: Highlight

Monday, 10:45-11:05, Highlight 2, Screen H4, BRK2.1-H4

• Martin Schultz (Herlev, Denmark):
“Availability of soluble urokinase plasminogen activator receptor at triage can provide an
accurate risk stratification in emergency departments: a sub-study of the triage iii trial

suPAR Hands-On

Tuesday, 12:45-13.15, Exhibition Hall 5

• Visit our “Emergency Room” at the Hands-On session and try doing a suPAR measurement.
Based on the result, decide whether you will discharge or admit your patient

e-Poster: Research

Sunday to Wednesday

• Robert Ivic (Sweden):
“Soluble urokinase plasminogen activator receptor and lactate as prognostic biomarkers in
patients presenting with non-specific complaints in the pre-hospital setting –The prius– trial”

Please find mor information on the conference here; EuSEM 2018 - 12'th European Congress on Emergency Medicine